LY3298176 displays glucose-dependent insulin secretion and enhances glucose tolerance by acting on equally GIP and GLP-one receptors in mice. Serious treatment with LY3298176 results in an important dose-dependent decrease in physique weight which is additional pronounced than that observed with sem